Overview
3CTN’s leadership strongly believes in the value of patient and public involvement (PPI) and is committed to ensuring that PPI is embedded in every aspect of the 3CTN framework, both at the Coordinating Centre level and at Network sites across the country.
One key part of 3CTN’s PPI efforts are the recruitment of Patient Representatives, who contribute a crucial perspective to clinical trials by providing feedback, insight, expertise and support towards trial activities and initiatives. This section contains helpful guides for new Patient Representatives joining the Network and information for patients and members of the public who are interested in learning more about academic cancer clinical trials.
